In a bid to augment India's Covid-19 vaccine production , the Centre has decided to support some public sector companies with grants under "Mission COVID Suraksha". One such company is the Hyderabad-based Indian Immunological limited (IIL), which a facility under the PSU, National Dairy Development Board. A technical collaboration agreement has been reached between IIL and Bharat Biotech, for IIL to supply the drug substance required for manufacturing of Covaxin to Bharat Biotech, an official statement read. The Managing Director of Indian Immunological Limited, Dr K Anand Kumar said the IIL is planning to start the production of drug substance for Covaxin from next month, 15 June, and send out the first batch to Bharat Biotech limited by July. Under Atmanirbhar Bharat 3.0, Mission COVID Suraksha was announced by the government, to accelerate the development and production of Indigenous COVID Vaccines.

Source: Mint May 28, 2021 12:43 UTC